Unlike GIP, the action of GLP-1 is preserved in patients with type 2 diabetes. Glucagon-like peptide-1 receptor agonists gained approval as drugs to treat diabetes and obesity starting in the 2000s.
In summary, our study highlights the role of HERG potassium channels in regulating GLP-1 secretion from intestinal L-cells. The downregulation of HERG leads to alterations in action potential duration, intracellular calcium levels, and GLP-1 secretion.
Subsequently, the effect of LB on cellular potassium channels was examined by membrane clamp, and the results showed that LB increased intracellular Ca2+ concentration and stimulated insulin secretion by activating GLP-1R and thus closing the ATP-sensitive potassium channels.
Such details provide a deeper understanding and appreciation for Lim Potassium Channel And Glp-1 Receptor Protein Association.
The study, recently published in Nature Communications, elucidates how GLP-1 activates ATP-sensitive potassium (K_ATP) channels in coronary pericytes, cells traditionally overshadowed by cardiomyocytes and endothelial cells in heart research.
s a regulator of neuronal activity, GLP1 or its analogue may comprise a new metabolic factor with a potential therapeutic target in the olfactory bulb (i.e. via intranasal delivery) for controlling an imbalance in energy homeostasis. GLP-1 has been shown to confer glucose-insensitive beta cells with glucose sensitivity by modulation of the activity of the ATP-sensitive potassium (KATP) channel. Does hERG regulate GLP-1 secretion in the intestine? These findings provide evidence that HERG plays a direct role in regulating GLP-1 secretion in the intestine and may hold promise as a potential target for the treatment of diabetes. The human ether-a-go-go-related gene ( HERG) encodes the HERG ion channel, which is a member of the voltage-dependent potassium channel (Kv) family. What are glucagon-like peptide-1 and GLP-1 receptor activators? Derived from enteroendocrine cells (EECs), glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are pivotal incretin hormones crucial for blood glucose regulation. Medications of GLP-1 analogs and GLP-1 receptor activators are extensively used in the treatment of type 2 diabetes (T2D) and obesity. What are GIP and GLP-1? GIP and GLP-1 are incretins secreted within minutes of nutrient intake in the gastrointestinal tract, which enhance glucose-stimulated insulin secretion. 4, 27, 31 The cellular mechanisms that control the endogenous secretion of incretins remain poorly understood. Is hERG-encoded potassium channel associated with reactive hypoglycemia? J. Physiol. 406, 115146, (1988). Hylten-Cavallius, L. et al. Patients with long-QT syndrome caused by impaired hERG-encoded Kv11.1 Potassium channel have exaggerated endocrine pancreatic and incretin function associated with reactive hypoglycemia. Our investigation reveals the expression of KCNH2 in GIP-producing K cells and GLP-1-producing L cells in mice. Notably, specific knockout of gut epithelial cells KCNH2 in mice enhances...
Furthermore, visual representations like the one above help us fully grasp the concept of Lim Potassium Channel And Glp-1 Receptor Protein Association.
GLP-1 has been shown to confer glucose-insensitive beta cells with glucose sensitivity by modulation of the activity of the ATP-sensitive potassium (KATP) channel.
